Postdoctoral Fellow
Michael started out working on CTD kinases, but this led to his pioneering work on histone modifying enzymes. In 2006 Michael started his own lab at Albert Einstein College of Medicine, and more recently he became the Chief Scientific Officer of the epigenetics company EpiCypher. Michael's LinkedIn profile.